DEXCOM INC - 8-K Filing

Dexcom reports Q3 2026 revenue of $1.344 billion and authorizes a new $1.0 billion share repurchase program. (Items: 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION, 9.01 FINANCIAL STATEMENTS AND EXHIBITS)

SEC EDGAR · October 29, 2026, 20:04 UTC

Tickers: $DXCM

Read the full article at SEC EDGAR

Part of the story PREFORMED LINE PRODUCTS CO - 8-K Filing (22 articles)

More Regulatory news

Boost Run Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
INTERFACE INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Neonode Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Virtuix Holdings Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Neonode Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:18 UTC
Beyond Air, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:17 UTC
Carter Bankshares, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:12 UTC
Marvell Technology, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:11 UTC
VISHAY INTERTECHNOLOGY INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:11 UTC
LATTICE SEMICONDUCTOR CORP - 4 Filing SEC EDGAR · November 12, 2026, 14:10 UTC